The aim of the present study was, therefore, to evaluate the impact of SGLT2 and glucose concentration levels on the progression of ccRCC with the VHL mutation using in vitro models that were not subject to the many potential confounders linked to DM in vivo. Here, SLC5A2 is linked to nonpapillary renal cell carcinoma.